119 related articles for article (PubMed ID: 15116210)
1. Towards configurationally stable bisindolylmaleimide cyclophanes: potential tools for investigating protein kinase function.
Bartlett S; Nelson A
Chem Commun (Camb); 2004 May; (9):1112-3. PubMed ID: 15116210
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of AX4697, a bisindolylmaleimide exo-affinity probe that labels protein kinase C alpha and beta.
Liu Y; Wu J; Weissig H; Betancort JM; Gai WZ; Leventhal PS; Patricelli MP; Samii B; Szardenings AK; Shreder KR; Kozarich JW
Bioorg Med Chem Lett; 2008 Nov; 18(22):5955-8. PubMed ID: 18774710
[TBL] [Abstract][Full Text] [Related]
3. Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.
Faul MM; Gillig JR; Jirousek MR; Ballas LM; Schotten T; Kahl A; Mohr M
Bioorg Med Chem Lett; 2003 Jun; 13(11):1857-9. PubMed ID: 12749884
[TBL] [Abstract][Full Text] [Related]
4. Configurational stability of bisindolylmaleimide cyclophanes: from conformers to the first configurationally stable, atropisomeric bisindolylmaleimides.
Barrett S; Bartlett S; Bolt A; Ironmonger A; Joce C; Nelson A; Woodhall T
Chemistry; 2005 Oct; 11(21):6277-85. PubMed ID: 16075446
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
Katoh M; Dodo K; Fujita M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic interactions of bisindolylmaleimide analogues.
Lazareno S; Popham A; Birdsall NJ
Eur J Pharmacol; 1998 Nov; 360(2-3):281-4. PubMed ID: 9851596
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
Wang K; Li XY; Chen XG; Liu ZZ
J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of bisindolylmaleimides using a palladium catalyzed cross-coupling reaction.
Neel DA; Jirousek MR; McDonald JH
Bioorg Med Chem Lett; 1998 Jan; 8(1):47-50. PubMed ID: 9871626
[TBL] [Abstract][Full Text] [Related]
9. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
[TBL] [Abstract][Full Text] [Related]
10. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.
Merritt JE; Sullivan JA; Drew L; Khan A; Wilson K; Mulqueen M; Harris W; Bradshaw D; Hill CH; Rumsby M; Warr R
Cancer Chemother Pharmacol; 1999; 43(5):371-8. PubMed ID: 10100591
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of protein kinase C (PKC) inhibitors staurosporine and bisindolylmaleimide I (GF109203X) on bone resorption.
Lee SK; Stern PH
Biochem Pharmacol; 2000 Oct; 60(7):923-6. PubMed ID: 10974200
[TBL] [Abstract][Full Text] [Related]
13. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
[TBL] [Abstract][Full Text] [Related]
14. Direct effect of protein kinase C inhibitors on cardiovascular ion channels.
Son YK; Hong DH; Kim DJ; Firth AL; Park WS
BMB Rep; 2011 Sep; 44(9):559-65. PubMed ID: 21944247
[TBL] [Abstract][Full Text] [Related]
15. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C.
Han Z; Pantazis P; Lange TS; Wyche JH; Hendrickson EA
Cell Death Differ; 2000 Jun; 7(6):521-30. PubMed ID: 10822275
[TBL] [Abstract][Full Text] [Related]
16. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor.
Coultrap SJ; Sun H; Tenner TE; Machu TK
J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762
[TBL] [Abstract][Full Text] [Related]
17. 3-(7-Azaindolyl)-4-indolylmaleimides as a novel class of mutant isocitrate dehydrogenase-1 inhibitors: Design, synthesis, and biological evaluation.
Hu Y; Gao A; Liao H; Zhang M; Xu G; Gao L; Xu L; Zhou Y; Gao J; Ye Q; Li J
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800039. PubMed ID: 30113716
[TBL] [Abstract][Full Text] [Related]
18. Na+/H+ exchanger 1 is regulated via its lipid-interacting domain, which functions as a molecular switch: a pharmacological approach using indolocarbazole compounds.
Shimada-Shimizu N; Hisamitsu T; Nakamura TY; Hirayama N; Wakabayashi S
Mol Pharmacol; 2014 Jan; 85(1):18-28. PubMed ID: 24136992
[TBL] [Abstract][Full Text] [Related]
19. An enantioselective strategy to macrocyclic bisindolylmaleimides. An efficient formal synthesis of LY 333531.
Trost BM; Tang W
Org Lett; 2001 Oct; 3(21):3409-11. PubMed ID: 11594846
[TBL] [Abstract][Full Text] [Related]
20. The microbial alkaloid toxin staurosporine blocks the phorbol ester-induced increase in beta-amyloid precursor protein in PC12 cells.
Friedman LM; Matsuda Y; Lazarovici P
Nat Toxins; 1997; 5(5):173-9. PubMed ID: 9496375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
